NNVC

NanoViricides (NNVC)

About NanoViricides (NNVC)

NanoViricides, Inc. is a clinical stage company, which engages in the development of nano-biopharmaceutical drugs against viruses. It focuses on anti-viral therapeutics through internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Details

Daily high

$1.01

Daily low

$0.94

Price at open

$1.00

52 Week High

$2.23

52 Week Low

$0.85

Market cap

21.2M

Dividend yield

0.00%

Volume

165,812

Avg. volume

249,786

P/E ratio

-2.04

NanoViricides News